AKSO HEALTH GR. (SPADR)/3 (8HX) - Net Assets
Based on the latest financial reports, AKSO HEALTH GR. (SPADR)/3 (8HX) has net assets worth €198.31 Million EUR (≈ $231.85 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€212.04 Million ≈ $247.90 Million USD) and total liabilities (€13.73 Million ≈ $16.05 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read AKSO HEALTH GR. (SPADR)/3 (8HX) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €198.31 Million |
| % of Total Assets | 93.52% |
| Annual Growth Rate | 153.03% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 687.96 |
AKSO HEALTH GR. (SPADR)/3 - Net Assets Trend (2022–2025)
This chart illustrates how AKSO HEALTH GR. (SPADR)/3's net assets have evolved over time, based on quarterly financial data. Also explore AKSO HEALTH GR. (SPADR)/3 (8HX) total assets for the complete picture of this company's asset base.
Annual Net Assets for AKSO HEALTH GR. (SPADR)/3 (2022–2025)
The table below shows the annual net assets of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025. For live valuation and market cap data, see market cap of AKSO HEALTH GR. (SPADR)/3.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €199.15 Million ≈ $232.83 Million |
+43.87% |
| 2024-03-31 | €138.42 Million ≈ $161.83 Million |
+1465.97% |
| 2023-03-31 | €8.84 Million ≈ $10.33 Million |
-28.05% |
| 2022-03-31 | €12.29 Million ≈ $14.36 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to AKSO HEALTH GR. (SPADR)/3's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14579607600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €398.02 Million | 199.89% |
| Total Equity | €199.12 Million | 100.00% |
AKSO HEALTH GR. (SPADR)/3 Competitors by Market Cap
The table below lists competitors of AKSO HEALTH GR. (SPADR)/3 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Longwell Co
TWO:6290
|
$1.60 Billion |
|
MY EG Services Bhd
KLSE:0138
|
$1.60 Billion |
|
Stagwell Inc
NASDAQ:STGW
|
$1.60 Billion |
|
Tong Hsing Electronic Industries Ltd
TW:6271
|
$1.60 Billion |
|
Fangda Special Steel Technology Co Ltd
SHG:600507
|
$1.60 Billion |
|
Nanjing Sciyon Automation Group Co Ltd
SHE:002380
|
$1.60 Billion |
|
DXC Technology Co
NYSE:DXC
|
$1.60 Billion |
|
eClerx Services Limited
NSE:ECLERX
|
$1.60 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AKSO HEALTH GR. (SPADR)/3's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 138,367,384 to 199,119,145, a change of 60,751,761 (43.9%).
- Net loss of 134,977,369 reduced equity.
- New share issuances of 195,884,024 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-134.98 Million | -67.79% |
| Share Issuances | €195.88 Million | +98.38% |
| Other Changes | €-154.89K | -0.08% |
| Total Change | €- | 43.91% |
Book Value vs Market Value Analysis
This analysis compares AKSO HEALTH GR. (SPADR)/3's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.40x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 9.05x to 13.40x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | €0.18 | €1.62 | x |
| 2023-03-31 | €0.13 | €1.62 | x |
| 2024-03-31 | €0.32 | €1.62 | x |
| 2025-03-31 | €0.12 | €1.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AKSO HEALTH GR. (SPADR)/3 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -913.38%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.08x
- Recent ROE (-67.79%) is below the historical average (-56.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -137.18% | -280.85% | 0.10x | 5.11x | €-18.08 Million |
| 2023 | -15.59% | -10.32% | 0.64x | 2.34x | €-2.23 Million |
| 2024 | -6.84% | -391.78% | 0.02x | 1.03x | €-23.30 Million |
| 2025 | -67.79% | -913.38% | 0.07x | 1.08x | €-154.89 Million |
Industry Comparison
This section compares AKSO HEALTH GR. (SPADR)/3's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,116,417,216
- Average return on equity (ROE) among peers: -25.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AKSO HEALTH GR. (SPADR)/3 (8HX) | €198.31 Million | -137.18% | 0.07x | $1.60 Billion |
| EDAP TMS S.A (EDA) | $40.90 Million | -50.33% | 1.10x | $128.94 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $7.92 Billion | 15.07% | 0.80x | $437.05 Million |
| CLOUDR GROUP LTD. (H3L) | $1.43 Billion | -36.04% | 0.99x | $42.29 Million |
| Medios AG (ILM1) | $34.10 Million | -9.30% | 0.40x | $367.06 Million |
| M1 Kliniken AG (M12) | $15.12 Million | 0.72% | 0.48x | $300.08 Million |
| Paragon Care Limited (PXS) | $82.69 Million | 12.30% | 1.01x | $130.61 Million |
| Sigma Healthcare Limited (S5YA) | $514.28 Million | 7.10% | 1.69x | $19.74 Billion |
| TELES Informationstechnologien AG (TLIK) | $1.61 Million | 16.62% | 0.77x | $2.20 Million |
| COSMOS HEALTH NEW DL-01 (V67A) | $4.38 Million | -181.80% | 10.29x | $14.30 Million |
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more